Taking two 7 mg Rybelsus tablets to achieve a 14 mg dose is not recommended
Long-term success still relies on sustainable nutrition, strength training, sleep, and stress regulation
Cons Compounded formulations are not the same as FDA-approved brand products, and long-term trial data are limited
Native GLP-1 has been infused by the subcutaneous route (4.8 pmol/kg/min) using a portable insulin pump in a non-randomized study of subjects with type 2 diabetes over the age of 40 (mean age 55) with mean initial HbA1c of about 9%, and mean fasting glucose ~14 mM
The combination of metformin with semaglutide or metformin with tirzepatide may offer the most comprehensive approach for former gestational diabetes patients
Medicare does not currently cover GLP-1s for obesity, but recently announced that they will be among the drug classes which the federal government will aim to negotiate in 2025